Medicine Man Technologies, Inc. (SHWZ)
OTCMKTS: SHWZ · Delayed Price · USD
0.541
+0.090 (20.11%)
May 16, 2024, 3:39 PM EDT - Market open
Medicine Man Technologies Revenue
Medicine Man Technologies had revenue of $41.73B in the twelve months ending March 31, 2024, with 24,800.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $41.60B with 103,900.05% year-over-year growth. In the year 2023, Medicine Man Technologies had annual revenue of $172.45M with 8.20% growth.
Revenue (ttm)
$41.73B
Revenue Growth
+24,800.23%
P/S Ratio
0.00
Revenue / Employee
$57,247,517
Employees
729
Market Cap
42.29M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 172.45M | 13.07M | 8.20% |
Dec 31, 2022 | 159.38M | 50.96M | 47.00% |
Dec 31, 2021 | 108.42M | 84.42M | 351.73% |
Dec 31, 2020 | 24.00M | 13.38M | 126.03% |
Dec 31, 2019 | 10.62M | 2.69M | 34.00% |
Dec 31, 2018 | 7.92M | 4.39M | 124.52% |
Dec 31, 2017 | 3.53M | 2.90M | 458.96% |
Dec 31, 2016 | 631.46K | -204.32K | -24.45% |
Dec 31, 2015 | 835.78K | 583.89K | 231.80% |
Dec 31, 2014 | 251.89K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
SHWZ News
- 1 day ago - Schwazze Announces First Quarter 2024 Financial Results - PRNewsWire
- 17 days ago - Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET - PRNewsWire
- 7 weeks ago - Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 2 months ago - Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET - PRNewsWire
- 2 months ago - From Seed to Profit: The Top Cannabis Penny Stocks to Watch - MarijuanaStocks
- 2 months ago - Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer - PRNewsWire
- 6 months ago - Schwazze Announces Third Quarter 2023 Financial Results - PRNewsWire
- 7 months ago - Schwazze Sets Third Quarter 2023 Conference Call for November 14, 2023 at 5:00 p.m. ET - PRNewsWire